Clinical trial
Carmustine Followed By Surgery in Treating Patients With Recurrent…
NCT00009854 · Direct Therapeutics, Industry · Unknown status
Key facts
| NCT number | NCT00009854 |
|---|---|
| Title | Carmustine Followed By Surgery in Treating Patients With Recurrent Supratentorial Malignant Glioma or Metastatic Brain Neoplasm |
| Official title | Phase I/II Study of Intratumoral Injection of DTI-015 Prior to Tumor Resection in Patients With Recurrent Malignant Glioma or Metastatic Neoplasm to Brain |
| Lead sponsor | Direct Therapeutics, Industry |
| Status | Unknown status |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Brain and Central Nervous System Tumors, Metastatic Cancer |
| Intervention type | Drug, Procedure |
| Interventions | carmustine in ethanol, conventional surgery |
| Start date | Jun 1, 2000 |
| First posted | Jan 27, 2003 |
| Last update posted | Nov 6, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: